The Hantzsch reaction for nitrogen-13 PET: preparation of [13N]nifedipine and derivatives

Construction and Preliminary Evaluation of Two 18F-Labeled Radiopharmaceuticals for Myocardial Perfusion Imaging

AIMS

PET myocardial perfusion imaging (MPI) is the gold standard for the noninvasive diagnosis of ischemic myocardial. Construction of 18F-labeled PET MPI probe showed benefits to reduce the imaging cost, and enhance the image quality and patient-friendliness.

METHODS

Two 18F-labeled MPI probes (18F-BoMPI) were developed. Detailed in vitro/vivo evaluation including photophysical properties, in vitro stability, myocardial cell uptake kinetics and mechanisms, cytotoxicity and IC50, biodistribution and plasma clearance curve were investigated. Resting and stressing myocardial perfusion PET imaging were performed in healthy and myocardial ischemic mice.

RESULTS

18F-BoMPI could be quickly labeled and easily postprocessed, and demonstrated excellent in vitro stability. Cell assays indicated that 18F-BoMPI exhibited mitochondria-targeting but potential-independent myocardial uptake. In vivo evaluation revealed the effective myocardial uptake and rapid background clearance. PET MPI confirmed effective probe accumulation in the healthy heart, but rapidly clearance in the background, making heart clearly delineated in the images. Ischemic myocardial could be clearly distinguished as the region of radioactivity sparsity in PET MPI.

CONCLUSION

The 18F-labeled probes showed great potentials to reduce the practicability threshold of PET MPI.

Radiosynthesis, Preclinical, and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds

The presence of positron emission tomography (PET) centers at most major hospitals worldwide, along with the improvement of PET scanner sensitivity and the introduction of total body PET systems, has increased the interest in the PET tracer development using the short-lived radionuclides carbon-11. In the last few decades, methodological improvements and fully automated modules have allowed the development of carbon-11 tracers for clinical use. Radiolabeling natural compounds with carbon-11 by substituting one of the backbone carbons with the radionuclide has provided important information on the biochemistry of the authentic compounds and increased the understanding of their in vivo behavior in healthy and diseased states. The number of endogenous and natural compounds essential for human life is staggering, ranging from simple alcohols to vitamins and peptides. This review collates all the carbon-11 radiolabeled endogenous and natural exogenous compounds synthesised to date, including essential information on their radiochemistry methodologies and preclinical and clinical studies in healthy subjects.

Non-invasive radionuclide imaging of trace metal trafficking in health and disease: "PET metallomics"

Several specific metallic elements must be present in the human body to maintain health and function. Maintaining the correct quantity (from trace to bulk) and location at the cell and tissue level is essential. The study of the biological role of metals has become known as metallomics. While quantities of metals in cells and tissues can be readily measured in biopsy and autopsy samples by destructive analytical techniques, their trafficking and its role in health and disease are poorly understood. Molecular imaging with radionuclides - positron emission tomography (PET) and single photon emission computed tomography (SPECT) - is emerging as a means to non-invasively study the acute trafficking of essential metals between organs, non-invasively and in real time, in health and disease. PET scanners are increasingly widely available in hospitals, and methods for producing radionuclides of some of the key essential metals are developing fast. This review summarises recent developments in radionuclide imaging technology that permit such investigations, describes the radiological and physicochemical properties of key radioisotopes of essential trace metals and useful analogues, and introduces current and potential future applications in preclinical and clinical investigations to study the biology of essential trace metals in health and disease.

Intrinsic-Unsaturation-Enriched Biporous and Chemorobust Cu(II) Framework for Efficient Catalytic CO2 Fixation and Pore-Fitting Actuated Size-Exclusive Hantzsch Condensation with Mechanistic Validation

Carbon dioxide (CO₂) utilization and one-pot Hantzsch condensation denote two important protocols pertinent to sustainable agenda because of the obvious advantages like reduction in chemical usage, short reaction time, and minimum waste generation. To this end, the astute combination of optimum-sized pore structure with built-in Lewis acid center in metal-organic frameworks (MOFs) can bring about such reactions under energetically favorable conditions and offer a step forward to size-exclusive catalysis. The chemoresistant and twofold interpenetrated Cu(II) framework CSMCRI-13 (CSMCRI = Central Salt & Marine Chemicals Research Institute) is built from a C₃-symmetric tricarboxylate ligand and an N,N'-donor linker that undergo incisive amalgamation of the paddle-wheel [Cu₂(COO)₄] secondary building unit (SBU) and the intrinsically unsaturated Cu(II) node with four coordination. The microporous structure features a dual-pore containing cage-like network with free oxygen-atom-enriched cavities and exhibits appreciable CO₂ adsorption with moderate MOF-CO₂ interaction in activated form (13a). Benefitting from both, the coordinatively frustrated metal center containing MOF acts as a highly synergistic and solvent-free catalyst in CO₂ cycloaddition reaction under an 8 bar CO₂ pressure at 70 °C in 6 h. The catalyst furnished admirable reactivity and fair recyclability with a wide range of substrates, wherein sterically encumbered and long-chain epoxides produced poor conversion. This MOF further executes highly regenerable Hantzsch condensation reaction under mild condition with superior activity to contemporary materials, where most of the 1,4-dihydropyridine derivatives are additionally characterized through the single-crystal X-ray diffraction analysis. Importantly, mechanistic proof of the tricomponent condensation involving built-in Lewis acid sites is validated from several control experiments and in-depth analytical studies. To the best of the single-step multicomponent reaction, substrate molecules having incompatible molecular dimension to that of pore size of the framework resulted insignificant conversion and demonstrated the first-ever pore-fitting-induced size selectivity in Hantzsch condensation.

Advancement in production of radiotracers

After introduction of the first commercial combined PET and/or CT technology in 2001, this diagnostic tool quickly became a clinical success and was considered the fastest growing diagnostic imaging technology ever. However, this technique is very dependent on the availability of positron emitting isotopes and radiochemistry to incorporate the radioactive isotopes into larger molecules of physiological interest. Within this review article a historical overview starting with the first applications of positron emitting isotopes in the 1930's is presented. Afterwards a more detailed presentation summarizing the physical basis and advancements in cyclotron technology is given. Radiochemical and/or pharmaceutical advancements are presented systematically for the most significant isotopes like ¹⁵O, ¹³N, ¹¹C, ¹⁸F and ⁶⁸Ga Besides these major PET isotopes, advancements of other radio-metals and future perspectives regarding application of new radionuclides will be discussed. Finally, very interesting new and compact accelerator technology and microfluidic chemical reaction approaches will be discussed. Especially, new compact accelerator technology might be new quantum leap within this radiodiagnostic technology and might result in even further prevalence, ultimately envisioned by the dose-on-demand concept that will be briefly discussed.